Glycine Peptide
From PeptideSciences101, the open peptide reference. · Last updated: October 7, 2025
This article is a stub. A peer-reviewed deep-dive is in preparation. Help contribute to expand it.
…
Overview
Simple peptide that improves sleep quality and reduces core temperature.
Reported benefits
Improved sleep quality, faster sleep onset, better morning alertness
Protocols & dosing
Typical dosage: 3-5 g (before bed).
Detailed dosing protocols have not yet been catalogued.
FDA & legal status
Glycine Peptide is not currently FDA-approved for any indication. It is generally classified as a research compound. Regulatory status varies by country.
| Country | Status |
|---|---|
| United States | Research use only |
| United Kingdom | Prescription-only / not licensed |
| Canada | Prescription-only / Schedule F if licensed |
| Australia | TGA-scheduled |
Vendor information
PeptideSciences101 does not endorse vendors. For transparency metrics and third-party testing notes, see the vendor directory.
Side effects & safety
Reported side effects: Very safe
References
No external sources have been catalogued for this article yet.
Related peptides
- Cerebrolysin — Neural restoration during sleep
- Cortexin — Neuropeptide for rest
- DSIP — Delta sleep-inducing peptide
- Epithalon — Circadian rhythm regulator
- GHK-Cu — Recovery enhancement peptide
- Melatonin Peptide Complex — Enhanced melatonin delivery
Categories: Sleep & Recovery